Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients

Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients

Abstract Background This single-arm phase II trial aimed to assess the effectiveness and safety of incorporating hyperthermia into salvage concurrent chemoradiotherapy (CCRT) for previously irradiated unresectable recurrent head and neck cancer. Methods We enrolled patients with non-metastatic recur...

Full description

Saved in:
Bibliographic Details
Main Authors: Kai-Lin Yang, Mau-Shin Chi, Chung-Yu Hao, Hui-Ling Ko, Yi-Ying Huang, Ren-Hong Wu, Hung-Chih Lai, Ying-Chu Lin, Sheng-Po Hao, Kwan-Hwa Chi
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Radiation Oncology
Subjects:
Recurrent head and neck cancer
Hyperthermia
Concurrent chemoradiotherapy
Online Access:https://doi.org/10.1186/s13014-025-02585-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13014-025-02585-z

Similar Items